A nomogram based on pretreatment clinical parameters for the prediction of inadequate biochemical response in primary biliary cholangitis

BACKGROUND: Ursodeoxycholic acid (UDCA) has been widely recommended as the first‐line drug for primary biliary cholangitis (PBC) in the current guidelines. However, its therapeutic effects are poor in nearly one‐third of patients. The early identification and intervention of these patients is crucia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Siyuan, Liu, Yansheng, Sun, Keshuai, Zhou, Xia, Ma, Shuoyi, Zhang, Miao, Zhou, Xinmin, Wang, Lu, Han, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676192/
https://www.ncbi.nlm.nih.gov/pubmed/32915500
http://dx.doi.org/10.1002/jcla.23501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676192/
https://www.ncbi.nlm.nih.gov/pubmed/32915500
http://dx.doi.org/10.1002/jcla.23501

Ejemplares similares